OTCPK:MEDVF - Post by User
Comment by
INXS1on Aug 17, 2020 8:52pm
96 Views
Post# 31420684
RE:RE:RE:Spectral Analytics to Launch Patient Trial for
RE:RE:RE:Spectral Analytics to Launch Patient Trial foronly if : The closing of the transaction to acquire a 40-per-cent interest in Spectral is conditional on Spectral securing IRB approval for human trials and submission of a successful in vitro study to the FDA satisfactory to Questcap and other customary closing conditions.